Pulse Biosciences, Inc. (PLSE)
Free
No email, no account, no signup.
Pulling latest news for Pulse Biosciences, Inc.…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Bioelectric medicine and medical technology
Market Cap
$1.3B
We're already tracking Pulse Biosciences, Inc. — here are the latest events we've registered
Recent News
- On May 4, 2026, Pulse Biosciences reported Q1 2026 results and announced the start of enrollment in its U.S. pivotal trial, NANOPULSE-AF, for the nPulse Cardiac Catheter System. The company also presented positive 12-month clinical data from its European feasibility study, showing a 90% freedom from atrial arrhythmias. Enrollment in the U.S. trial is now expected to be completed in early Q4 2026.
Want to know how this news affects Pulse Biosciences, Inc.? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Pulse Biosciences, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.